Amalgamated Bank Ampio Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $5,075 - $14,908	-31,720 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.42 - $0.62 $1,114 - $1,645	-2,654 Reduced 7.72%	31,720 $15,000
Q4 2021 Feb 15, 2022	SELL	$0.56 - $1.71 $525 - $1,605	-939 Reduced 2.66%	34,374 $20,000
Q3 2021 Oct 29, 2021	SELL	$1.21 - $1.8 $733 - $1,090	-606 Reduced 1.69%	35,313 $59,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $56,033 - $71,119	35,919 New	35,919 $60,000
Q2 2019 Aug 14, 2019	SELL	$0.39 - $0.7 $5,761 - $10,341	-14,774 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.43 - $0.68 $225 - $357	525 Added 3.68%	14,774 $8,000
Q4 2018 Feb 15, 2019	BUY	$0.39 - $0.7 $5,557 - $9,974	14,249 New	14,249 $6,000
Q3 2018 Nov 14, 2018	SELL	$0.44 - $3.02 $5,524 - $37,919	-12,556 Closed	0 $0
Q2 2018 Jul 18, 2018	BUY	$1.66 - $3.82 $20,842 - $47,963	12,556 New	12,556 $28,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.